Importance of phenolic address groups in opioid kappa receptor selective antagonists

被引:20
|
作者
Thomas, JB
Fix, SE
Rothman, RB
Mascarella, SW
Dersch, CM
Cantrell, BE
Zimmerman, DM
Carroll, FI
机构
[1] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
[2] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] NIDA, Clin Psychopharmacol Sect, IRP, NIH, Baltimore, MD 21224 USA
关键词
D O I
10.1021/jm030467v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In vitro characterization and comparison of JDTic, its dehydroxy analogue and nor-BNI, and its dehydroxy analogue demonstrates that the N-substituted 3,4-dimethyl-(3-hydroxyphenyl)-piperidine-derived antagonist, JDTic, relies more heavily on its phenol address group for affinity and antagonist activity relative to the corresponding naltrexone derived antagonists, nor-BNI. The structural flexibility of the former class of compound relative to the latter is postulated to underlie the difference.
引用
收藏
页码:1070 / 1073
页数:4
相关论文
共 50 条
  • [31] Discovery and characterization of a new kappa selective opioid receptor antagonist
    Mitch, Charles H.
    Quimby, Steven
    Matt, James
    Diaz, Nuria
    Pedregal, Concepcion
    De La Torre, Marta
    Shi, Qing
    Canada, Emily
    McKinzie, David
    Statnick, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [32] Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review
    Wong, Sabrina
    Le, Gia Han
    Vasudeva, Shreya
    Teopiz, Kayla M.
    Phan, Lee
    Meshkat, Shakila
    Kwan, Angela T. H.
    Rhee, Taeho Greg
    Ho, Roger
    Choi, Hayun
    Cao, Bing
    Rosenblat, Joshua D.
    Mcintyre, Roger S.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 362 : 816 - 827
  • [33] AGONISTS AND ANTAGONISTS BIND TO DIFFERENT DOMAINS OF THE CLONED KAPPA-OPIOID RECEPTOR
    KONG, HY
    RAYNOR, K
    YANO, H
    TAKEDA, J
    BELL, GI
    REISINE, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) : 8042 - 8046
  • [34] Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
    Xie, Jennifer Y.
    De Felice, Milena
    Kopruszinski, Caroline M.
    Eyde, Nathan
    LaVigne, Justin
    Remeniuk, Bethany
    Hernandez, Pablo
    Yue, Xu
    Goshima, Naomi
    Ossipov, Michael
    King, Tamara
    Streicher, John M.
    Navratilova, Edita
    Dodick, David
    Rosen, Hugh
    Roberts, Ed
    Porreca, Frank
    CEPHALALGIA, 2017, 37 (08) : 780 - 794
  • [35] Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
    Jacobson, Moriah L.
    Browne, Caroline A.
    Lucki, Irwin
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60, 2020, 60 : 615 - 636
  • [36] Preclinical Disposition (In Vitro) of Novel μ-Opioid Receptor Selective Antagonists
    Mitra, Pallabi
    Venitz, Juergen
    Yuan, Yunyun
    Zhang, Yan
    Gerk, Phillip M.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (09) : 1589 - 1596
  • [37] 7-arylidenenaltrexones as selective δ1 opioid receptor antagonists
    Ohkawa, S
    Portoghese, PS
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) : 4177 - 4180
  • [38] Stilbenes as κ-Selective, Non-nitrogenous Opioid Receptor Antagonists
    Hartung, Alyssa M.
    Beutler, John A.
    Navarro, Hernan A.
    Wiemer, David F.
    Neighbors, Jeffrey D.
    JOURNAL OF NATURAL PRODUCTS, 2014, 77 (02): : 311 - 319
  • [39] Naltrindole analogs as potent and selective κ-opioid receptor antagonists.
    Stevens, WC
    Jones, RM
    Subramanian, G
    Ferguson, DM
    Portoghese, PS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1005 - U1006
  • [40] Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats
    Varaschin, Rafael Koerich
    Morato, Gina Struffaldi
    PSYCHOPHARMACOLOGY, 2009, 206 (01) : 85 - 96